ORIGINAL ARTICLE |
|
Year : 2023 | Volume
: 13
| Issue : 1 | Page : 9-16 |
|
Quercetin modulates ovarian autophagy–related molecules and stereological parameters in a rat model of PCOS
Asma Neisy1, Farhad Koohpeyma2, Majid Jafari Khorchani3, Fatemeh Karimi4, Fatemeh Zal1
1 Department of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran 2 Physiology, Endocrine and Metabolism Research Center, Shiraz University of Medical Science, Shiraz, Iran 3 Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran 4 Histomorphometry and Stereology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Correspondence Address:
Fatemeh Zal Department of Biochemistry, School of Medicine, Shiraz University of Medical Sciences, Shiraz Iran
 Source of Support: This work was supported by the Shiraz University of Medical Sciences (grant number: 10774), Conflict of Interest: None
DOI: 10.4103/2221-1691.367686
|
|
Objective: To examine the effect of quercetin on stereological parameters and autophagy-related genes in ovaries of polycystic ovary syndrome (PCOS) rats.
Methods: Fifty female Sprague-Dawley rats were randomly divided into five groups: the control group, the ethanol group, the quercetin group (15 mg/kg/day), the PCOS group, as well as the PCOS + quercetin group. After the induction of PCOS, quercetin was administered orally for 30 days. Histological, stereological and real-time PCR analyses were carried out to evaluate the effect of quercetin on PCOS rats.
Results: Stereological analysis revealed that quercetin significantly increased the number of ovarian follicles and the volume of corpus luteum and induced a significant decrease in atretic follicles in comparison to the PCOS group. In addition, quercetin markedly increased mTOR gene expression while decreasing Beclin-1 and LC3 gene expression.
Conclusions: Quercetin strongly modulates the expression of ovarian autophagy-related genes and stereological parameters in PCOS rats. Therefore, it can be considered as an ameliorative component for ovarian follicular impairments.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|